In 2003, multiple investigators reported that peripheral blood cells from systemic lupus erythematosus (SLE) patients demonstrated an overexpression of a characteristic pattern of ISGs, termed an IFN signature (3–5). This evidence concerns the gene IFNA1 and systemic lupus erythematosus.